Results of the ENPAC Trial Shows Promise in Recurrent Endometroid Cancer
November 1st 2022Shannon N. Westin, MD, MPH, discusses the promising results of the ENPAC trial that showed the effectiveness of adding enzalutamide to standard of care chemotherapy for patients with recurrent endometriod cancer.